Zullo Investment Group, Inc. Moderna, Inc. Transaction History

Zullo Investment Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$135.66 - $197.02 $5,426 - $7,880	40 Added 3.03%	1,359 $208,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $3,551 - $6,301	30 Added 2.33%	1,319 $236,000
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $15,349 - $25,243	-130 Reduced 9.16%	1,289 $152,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $3,161 - $5,876	25 Added 1.79%	1,419 $244,000
Q4 2021 Feb 16, 2022	BUY	$225.82 - $368.51 $314,793 - $513,702	1,394 New	1,394 $354,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Zullo Investment Group, Inc. with notifications on news.